MUC1 and adenocarcinoma: In Posey et al.’s study, CAR T cells targeting the MUC1 Tn glycoform demonstrated significant efficacy against adenocarcinoma, effectively controlling tumor growth and specifically targeting abnormal MUC1 glycosylation in multiple cancer types (124).